Biology

Frontage Global Drug Discovery Services (GDDS) develops and optimizes high-fidelity biochemical and cellular assays to evaluate compound activity, selectivity and mechanism of action.

Download Fact Sheet
Biology
IN THIS SECTION

Understanding disease biology has been at the center of modern drug discovery

At Frontage Global Drug Discovery Services (GDDS), we offer a comprehensive compound screening platform with a wide range of enzymatic and cell-based assays.

Our experienced team of scientists routinely develop and validate new screening assays to support target selection.

Biology Services

Enzymatic AssayCell-based AssayCell Line GenerationPatch ClampIn vivo Efficacy
• Kinase
• Epigenetics Enzyme
• PARPSs
• Phospho
• Protease
• Kinase Panel
• Cell Proliferation
• CCK8/CTG/Dyquant/3D Assay
• Cell Panel
• LANCE/HTRF/Alpha screen cell WB

• Nuclear receptor
• GPCR
• Ion Channel
• Over expression cell lines
• hERG
• Nave1.5
• DRG
• CDX
• Syngeneic
• PBMC humanized CDX
• Combo with ICI

Biochemical and Cell Based Assays

Frontage GDDS offers a comprehensive suite of kinase and cancer panels.

275+ kinases, extensive cancer panel of 250+ tumor cell lines, and a panel of 100+ GPCR cell lines.

Our service includes but not limited to the following:

  • Mutant and wild-type cells
  • Individual kinases and kinase panels
  • Tumor cell panels
  • GPCR cell panels
  • Epigenetic enzymes
  • DNA repair enzymes
  • Phosphodiesterases
  • Proteolytic enzymes
  • Human whole blood and PBMC Assays
  • Platforms Include:

Platforms Include:

  • MTT/Cell-Titer Glo/CCK8/Cyquant
  • LANCE/HTRF/Alpha
  • Reporter gene assays
  • ELISA
  • MSD
  • Flow Cytometry (FACS)
  • Western Blotting
  • Gene Expression (qRT-PCR)
  • Manual Patch Clamp

Customized De Novo Assay Development

Frontage GDDS provides customized de novo assay development for specific targets. We have established more than a dozen FACS assays for the Jak/Tyk2-Stat pathway to dissect the effects of various cytokines and individual Jak/Tyk2 kinases using human PBMC.

GDDS also supports protein therapeutics including antibodies and ADC’s by measuring antibody concentrations using ELISA or MSD. We can customize your assays based on your specified antibodies and antigens or identify and obtain potential antibodies and antigens for your target. Our screening services are supported by a team of scientists with extensive experience in drug screening assays and utilize a full suite of automation equipment that supports 384-w and 96-w formats.